Overweight management: A cross-sectional study with special insight on metformin use in obesity control

Safa’a Ali Al-Qudah; Khawla Damen Al-Hamaideh; Isra Mahmoud Dmour; Samar Sameer Al Sbaihi

Abstract

The aim of the current study is to assess the attitudes and behavior of the Jordanian public toward weight management and to compare their different approaches to weight loss with a special emphasis on metformin’s role in weight reduction. This is a questionnaire-based study completed by 574 Jordanians. The results showed that 78.2% of the participants were overweight despite the different approaches used by Jordanians for weight management, including diet (64.8%), exercise (47.7%), and herb use (20.2%), in addition to the use of medications and dietary supplements (16.6% and 12.4%, respectively). It was found that 40.6% of the study sample used metformin for different causes, including weight control (19.3%). About 40% noticed weight loss in different ranges of kilograms at different durations of time, while more than half of the users (54.5%) did not notice any weight loss. 32.2% used diet while using metformin for weight loss compared to 50.2% that used exercises in addition to metformin for control of weight. In conclusion, being overweight is a health problem in Jordan. Lifestyle changes, including diet and exercise, were the most adopted approaches by the Jordanians for weight loss. Besides, different weight reduction responses to metformin were verified, and further clinical studies are needed to evaluate the exact weight reduction effect of metformin.

Keyword: Metformin obesity overweight weight loss Jordan.

Citation:

Al-Qudah SA, Al-Hamaideh KD, Dmour IM, Al Sbaihi SS. Overweight management: A cross-sectional study with special insight on metformin use in obesity control. J Appl Pharm Sci, 2022. Online First.

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reference

Abdel-Qader DH, Albassam A, Ismael NS, Aljamal MS, Chen LC, Mansoor K, Hamadi S, Al Mazrouei N, Al Meslamani AZ. Herbal medicine use in the Jordanian population: a nationally representative crosssectional survey. J Pharm Pharmacogn Res, 2020; 8:525-36.

Abu-Taha M, Daghash A, Daghash R, Abu Farha R. Evaluation of women knowledge and perception about polycystic ovary syndrome and its management in Jordan: a survey-based study. Int J Clin Pract, 2020; 74(10):e13552. https://doi.org/10.1111/ijcp.13552

Ajlouni K, Khader Y, Batieha A, Jaddou H, El-Khateeb M. An alarmingly high and increasing prevalence of obesity in Jordan. Epidemiol Health, 2020; 42:e2020040. https://doi.org/10.4178/epih.e2020040

Al-Eitan LN, Almomani BA, Nassar AM, Elsaqa BZ, Saadeh NA. Metformin pharmacogenetics: effects of SLC22A1, SLC22A2, and SLC22A3 polymorphisms on glycemic control and HbA1c levels. J Pers Med, 2019; 9(1):17. https://doi.org/10.3390/jpm9010017

Al-Qallaf, S. M. Efficacy and safety of metformin in weight loss in Bahraini population. J Appl Pharm Sci, 2016; 6(6):91-5. https://doi.org/10.7324/JAPS.2016.60616

Al-Rahamneh, H. The prevalence of obesity, overweight, and thinness among Jordanian children and adolescents. J Exercise Physiol Online, 2020; 23(2):95-108.

Al-Safi SA, Ayoub NM, Ayoub AM, Al-Momany E, Al-Doghim I, Al-Balas M, Alkofahi A, Aboul-Enein FH, Aboul-Enein BH. Public awareness of the abuse of herbs and drugs to decrease body weight: a novel national survey in Jordan. J Public Health, 2008; 16(3):205-13. https://doi.org/10.1007/s10389-007-0166-5

Apovian C. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care, 2016; 22(7 Suppl): s176-85.

Arroyo-Johnson C, Mincey K. Obesity epidemiology worldwide. Gastroenterol Clin, 2016; 45(4):571-9. Badran M, Laher I. Obesity in Arabic-speaking countries. J Obes, 2011; 2011:686430. https://doi.org/10.1016/j.gtc.2016.07.012

Bray GA, Frühbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet, 2016; 387(10031):1947-56. https://doi.org/10.1016/S0140-6736(16)00271-3 Burke LE, Wang J, Sevick MA. Self-monitoring in weight loss: a systematic review of the literature. J Am Diet Assoc, 2011; 111(1):92-102. https://doi.org/10.1016/S0140-6736(16)00271-3

Coll AP, Chen M, Taskar P, Rimmington D, Patel S, Tadross JA, Patel S, Tadross JA, Cimino I, Yang M, Welsh P, Virtue S, Goldspink DA, Miedzybrodzka EL, Konopka AR, Esponda RR, Huang JT, Tung YCL, Rodriguez-Cuenca S, Tomaz RA, Harding HP, Melvin A, Yeo GSH, Preiss D, Vidal-Puig A, Vallier L, Nair KS, Wareham NJ, Ron D, Gribble FM, Reimann F, Sattar N, Savage DB, Allan BB, O'Rahilly S. GDF15 mediates the effects of metformin on body weight and energy balance. Nature, 2020; 578(7795):444-48; doi: 10.1038/s41586-019-1911-y https://doi.org/10.1038/s41586-019-1911-y

Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care, 2012; 35(4):731-7. https://doi.org/10.2337/dc11-1299

Eanes L. Obesity a persistent global health problem. Int Arch Nurs Health Care, 2015; 1:1-3. https://doi.org/10.23937/2469-5823/1510014

Ejtahed HS, Tito RY, Siadat SD, Hasani-Ranjbar S, HoseiniTavassol Z, Rymenans L, Verbeke K, Soroush AR, Raes J, Larijani B. Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial. Eur J Endocrinol, 2019; 180(3):165-76. https://doi.org/10.1530/EJE-18-0826

Fruh, S. M. Obesity: risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract, 2017; 29(S1):S3-14. https://doi.org/10.1002/2327-6924.12510

Ghosal S, Ghosal S. The side effects of metformin-a review. J Diabetes Metab Disord, 2019; 6:030. https://doi.org/10.24966/DMD-201X/100030

Hakooz N, Jarrar YB, Zihlif M, Imraish A, Hamed S, Arafat T. Effects of the genetic variants of organic cation transporters 1 and 3 on the pharmacokinetics of metformin in Jordanians. Drug Metab Pers Ther, 2017; 32(3):157-62. https://doi.org/10.1515/dmpt-2017-0019

Higuera-Hernández MF, Reyes-Cuapio E, Gutiérrez-Mendoza M, Rocha NB, Veras AB, Budde, H, Jesse J, Zaldívar-Rae J, BlancoCenturión C, Machado S, Murillo-Rodríguez E. Fighting obesity: nonpharmacological interventions. Clin Nutr ESPEN, 2018; 25:50-5. https://doi.org/10.1016/j.clnesp.2018.04.005

Issa R. Research article use of herbal remedies, conventional medicine, diet and exercise for weight loss: case study of university students in Jordan. Pak J Nutr, 2018; 17:76-88. https://doi.org/10.3923/pjn.2018.76.88

Kahan S. Overweight and obesity management strategies. Am J Manag Care, 2016; 22:S186-96.

Kay JP, Alemzadeh R, Langley G, D'angelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metab Clin Exp, 2001; 50(12):1457-61. https://doi.org/10.1053/meta.2001.28078

Khalil H, Ellwood L, Lord H, Fernandez R. Pharmacological treatment for obesity in adults: an umbrella review. Ann Pharmacother, 2020; 54(7):691-705. https://doi.org/10.1177/1060028019898912

Lim SS, Norman RJ, Clifton PM, Noakes M. The effect of comprehensive lifestyle intervention or metformin on obesity in young women. Nutr Metab Cardiovasc Dis, 2011; 21(4):261-68. https://doi.org/10.1016/j.numecd.2009.10.006

Liu Y, Sun M, Yao H, Liu Y, Gao R. Herbal medicine for the treatment of obesity: an overview of scientific evidence from 2007 to 2017. Evid Based Complement Altern Med, 2017. https://doi.org/10.1155/2017/8943059

Londoño-Lemos ME. Pharmacological advances to the treatment of obesity. J Child Obes, 2018; 3(1):3. https://doi.org/10.21767/2572-5394.100043

Lv Z, Guo Y. Metformin and its benefits for various diseases. Front Endocrinol, 2020; 11:191. Malin SK, Kashyap SR. Effects of metformin on weight loss: potential mechanisms. Curr Opin Endocrinol Diabetes Obes, 2014; 21(5):323-9. https://doi.org/10.3389/fendo.2020.00191

Omer T. The causes of obesity: an in-depth review. Adv Obes Weight Manag Control, 2020; 10(4):90-4. https://doi.org/10.15406/aowmc.2020.10.00312

bOmer T. The health and economic impacts of obesity. Adv Obes Weight Manag Control, 2020; 10(4):96-8. https://doi.org/10.15406/aowmc.2020.10.00313

Piche ME, Auclair A, Harvey J, Marceau S, Poirier P. How to choose and use bariatric surgery in 2015. Canad J Cardiol, 2015; 31(2):153-66. https://doi.org/10.1016/j.cjca.2014.12.014

Pu R, Shi D, Gan T, Ren X, Ba Y, Huo Y, Bai Y, Zheng T, Cheng N. Effects of metformin in obesity treatment in different populations: a meta-analysis. Ther Adv Endocrinol Metab, 2020; 11:2042018820926000. https://doi.org/10.1177/2042018820926000

Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia, 2017; 60(9):1577-85. https://doi.org/10.1007/s00125-017-4342-z

Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med, 2019; 19(3):205. https://doi.org/10.7861/clinmedicine.19-3-205

Sam S, Ehrmann DA. Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome. Diabetologia, 2017; 60(9):1656-61. https://doi.org/10.1007/s00125-017-4306-3

Seifarth C, Schehler B, Schneider HJ. Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Exp Clin Endocrinol Diabetes, 2013; 121(01):27-31. https://doi.org/10.1055/s-0032-1327734

Shehadeh MB, Suaifan G, Abu-Odeh A, Darwish R. Complementary and alternative medicine use for weight management among females in Jordan: a community-based survey. East Mediterran Health J, 2020; 26(4). https://doi.org/10.26719/emhj.19.098

Solymár M, Ivic I, Pótó L, Hegyi P, Garami A, Hartmann P, Pétervári E, Czopf L, Hussain A, Gyöngyi Z, Sarlós P, Simon M, Mátrai P, Bérczi B, Balaskó M. Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly-a meta-analysis. PLoS One, 2018; 13(11):e0207947. https://doi.org/10.1371/journal.pone.0207947

Van Gaal L, Dirinck E. Pharmacological approaches in the treatment and maintenance of weight loss. Diabetes Care, 2016; 39(Supplement 2):S260-67. https://doi.org/10.2337/dcS15-3016

Wadden TA, Tronieri JS, Butryn ML. Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol, 2020; 75(2):235. https://doi.org/10.1037/amp0000517

Yerevanian A, Soukas AA. Metformin: mechanisms in human obesity and weight loss. Curr Obes Rep, 2019; 8(2):156-64. https://doi.org/10.1007/s13679-019-00335-3

Zhou J, Massey S, Story D, Li L. Metformin: an old drug with new applications. Int J Mol Sci, 2018; 19(10):2863. https://doi.org/10.3390/ijms19102863

Abstract

HTML Full Text

Reference

Article Metrics

Related Search

Citiaion Alert By Google Scholar

Similar Articles